Although the classical role of peroxisome proliferator-activated receptor ? or ? (PPAR?) is to regulate genes involved in fatty acid synthesis, PPAR? is highly expressed in the CNS and it participates in many brain functions including myelination. Being a nuclear hormone receptor, PPAR? needs ligand(s) for its activation and nuclear translocation. Although there are many synthetic ligands of PPAR?, nothing is known about the physiological activation of PPAR? by endogenous ligands in the brain. Therefore, we have identified three possible physiological ligands [1,3-di-tert-butylbenzene (DBB); 2,4-di-tert-butylphenol (DBP); hexadecanoic acid, methyl ester (HAM)] of PPAR? from nuclear extracts of mouse cerebellum. Here, by using in silico interaction studies, time-resolved FRET analyses, thermal shift assay, site-directed mutagenesis, and mass spectrometry, we will characterize whether these physiological molecules are true ligands with PPAR?. Furthermore, we would like to examine whether these cerebellar ligands exhibit promyelinating effect via PPAR?. A positive outcome of this grant proposal will highlight the discovery of novel cerebellar ligands of PPAR?, allowing us to develop cerebellum-based drugs in the future to promote remyelination in demyelinating disorders.

Public Health Relevance

Although there are many synthetic ligands of PPAR?, nothing is known about the physiological activation of PPAR? by endogenous ligands in the brain. We have identified three possible physiological ligands of PPAR? from the cerebellum and here, we would like to examine whether these cerebellar ligands truly interact with PPAR? and exhibit promyelinating effect via PPAR?. A positive outcome of this grant proposal will highlight the discovery of novel cerebellar ligands of PPAR?, allowing us to develop cerebellum-based drugs in the future to support remyelination in demyelinating disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS097426-01
Application #
9155665
Study Section
Cellular and Molecular Biology of Glia Study Section (CMBG)
Program Officer
Morris, Jill A
Project Start
2016-07-01
Project End
2018-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$193,750
Indirect Cost
$68,750
Name
Rush University Medical Center
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kundu, Madhuchhanda; Roy, Avik; Pahan, Kalipada (2017) Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-?. Proc Natl Acad Sci U S A 114:11482-11487